Orbem website preview
growth food Munich 3 sources
Own this company? Claim the page to unlock editing and verified-owner badge.

Orbem uses AI-powered MRI to reveal hidden biological data and provide actionable intelligence to help customers reduce waste and increase transparency.

Classification

Munich DE growth food saas b2b aibioinformatics AIHealthWellnessPersonalizedInsights

Profile

Founded
2019
Headcount
170+
Tech stack
AI-powered MRI

Funding

Funding details not yet available.

Business model
💡 Value Proposition

AI-powered MRI technology that reveals hidden biological knowledge, turning it into actionable intelligence to reduce waste and increase transparency.

👥 Customer Segments

Innovators and organizations worldwide seeking to gain deep insights into biological processes and improve operational transparency.

💰 Revenue Model
  • Hardware sales - upfront price for MRI scanner units (tiered by throughput)
📡 Channels

Direct sales force - dedicated account teams for poultry and produce sectors (Europe, US) · Strategic OEM partnerships (e.g., Vencomatic) that integrate Orbem scanners into hatchery equipment · Industry exhibitions & trade shows (e.g., Fruit Logistica, World Poultry Expo) for lead generation

🤝 Key Partnerships

Equipment OEMs (e.g., Vencomatic) for integrated hatchery solutions · Agricultural research institutes (e.g., Fraunhofer, Wageningen) for joint validation studies · Funding bodies & investors - EU Horizon Europe, Innovation Industries, Supernova Invest (Series B)[2]

⚖️ Cost Structure

R&D, AI technology development

🏗️ Key Resources

Proprietary AI-powered MRI technology and automated solutions for generating deep biological insights.

⚙️ Key Activities

Developing AI-powered MRI tools and providing automated solutions to uncover hidden biological data for customers.

💬 Customer Relationships

High-touch, solution-selling - on-site engineering support during installation and calibration · Managed service contracts - routine maintenance, software updates, and AI model retraining · Data-sharing agreements - customers receive analytics dashboards; Orbem retains anonymized data for R&D

Strategic analysis
🏁 Competitive landscape

Competes in the biotech and food inspection space using non-invasive imaging; differentiates through proprietary AI-powered MRI that reveals hidden biological insights compared to traditional invasive or surface-level testing methods.

🎯 Market pains

Need for transparency in biological processes and the challenge of reducing waste through better understanding of hidden biological factors.

💎 Improvement suggestions
  • Introduce a tiered SaaS model (e.g., per-scan vs. unlimited) to capture price-sensitive growers while upselling high-volume processors
♟️ Strategic implications
  • Map current customer contracts to identify upsell opportunities for SaaS subscriptions · How can Orbem transition from a hardware-centric model to a platform-as-a-service (PaaS) ecosystem? · What are the key regulatory milestones for MRI-based food imaging in the United States?
🔗 Inter-block dynamics

OEM partnerships and direct sales channels drive hardware revenue, while data-sharing agreements feed the AI R&D that sustains the core value proposition.

🛡️ Credibility notes
  • Strong financial backing - €55.5 M Series B round led by top-tier investors signals confidence in scalability and market potential[2]
Team

Team details not yet available.

Investors

No investors recorded yet.

Sources & references

Web verified · 3 sources
Enriched 18 Jun 2026